Tinidan

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tinidan

Property Description
Active ingredient Tinidazole (Tinidazolum)
Form Film-coated tablet, Liquid suspension
Pharmacological class Nitroimidazole antimicrobial
General purpose Anti-infective (Antiprotozoal/Anaerobic antibacterial)
Origin Synthetic

What is Tinidan, and What Class of Medicine Does It Belong To?

Tinidan is a prescription-only medication that functions as a powerful anti-infective drug, belonging specifically to the Nitroimidazole antimicrobial class. The medicinal entity contains one active component, Tinidazole (Tinidazolum), which is used to eliminate infections caused by susceptible pathogens. Tinidazole is a synthetic compound with a structure that enables broad spectrum activity against specific parasites (antiprotozoal action) and bacteria that live in low-oxygen environments (anaerobic antibacterial action). This medication is used for treating infections in adults and pediatric patients older than three years of age.


Composition and Form: Is Tinidan Synthetic?

The drug Tinidan is a single-ingredient product utilizing Tinidazole as its sole active component, confirming its status as an entirely synthetic entity derived from the nitroimidazole chemical group. For patient convenience and systemic absorption, Tinidan is primarily supplied for the oral route in two main dosage form(s): a film-coated tablet and a liquid suspension. The availability of the liquid suspension facilitates administration for patients who have difficulty swallowing solids, such as some pediatric patients. The formulation uses standard inert excipients as a base or vehicle, ensuring the precise delivery and stability of the Tinidazole to facilitate its absorption into the body.


What is the General Purpose of Tinidan?

The overall purpose of Tinidan is to clear the body of specific harmful protozoal organisms and anaerobic bacteria, thereby halting the disease processes they initiate. This therapeutic effect is achieved because Tinidazole acts as a prodrug; it is designed to become biochemically activated only inside the target microbes. Tinidazole is characterized by high bioavailability and a prolonged serum half-life, which leads to effective plasma concentrations for treating susceptible infections. This means the drug is readily available in the body and stays active for a longer time compared to some analogues, which helps it effectively fight the infection.

Regulatory References

  1. U.S. National Library of Medicine

What side effects are possible with Tinidan?

Official Adverse Reactions and Safety Characteristics

The safety profile of Tinidan (Tinidazole) is formally defined by regulatory agencies, classifying potential adverse reactions by frequency and the physiological systems affected. The most frequently documented effects are categorized as Common and involve the Gastrointestinal and Nervous Systems.


Safety Patterns by Organ System

Gastrointestinal Disorders commonly include nausea, vomiting, and a change in taste often described as a metallic or bitter taste. Other reported effects include abdominal pain and decreased appetite. Within Nervous System Disorders, common effects are documented as headache and dizziness.

Adverse reactions affecting the Blood and Lymphatic System Disorders, such as transient neutropenia and leukopenia (decreases in certain white blood cells), are generally classified as Uncommon. Changes in urine color, leading to darkened urine, are also a documented effect.

Serious Adverse Reactions and Duration-Related Safety

The official label highlights certain rare but serious adverse reactions. These include seizures and severe forms of peripheral neuropathy (numbness or tingling). Peripheral neuropathy is specifically noted as a safety consideration associated with prolonged administration of the drug. Serious events in the Immune System Disorders class, such as severe hypersensitivity reactions, are also documented safety concerns.

Population-Specific Safety Constraints

Safety constraints noted in regulatory documents must be considered. Tinidan is contraindicated in patients with a known history of hypersensitivity to Tinidazole or other drugs in the nitroimidazole class. Caution is advised for use in individuals with severe hepatic impairment, as the drug's clearance may be significantly reduced. Furthermore, the use of Tinidan is also contraindicated in patients with Cockayne Syndrome due to the risk of irreversible liver damage.

Overdose and Emergency Response

The regulatory information for Tinidan (Tinidazole) overdose notes a lack of consistent clinical data regarding the specific signs and symptoms of overdosage in humans, with available reports described as anecdotal. This constraint necessitates strict adherence to official emergency protocols. In any case of suspected overdosage, it is officially required to seek emergency medical attention immediately. The Poison Control Helpline should be contacted for guidance.

Emergency services must be contacted urgently if the person who has overdosed is exhibiting severe, life-threatening clinical manifestations such as a seizure, collapse, or trouble breathing.

The official management strategy documented in regulatory sources consists of providing symptomatic and supportive treatment, as no specific antidote is known for Tinidazole overdosage. Procedural options mentioned in regulatory text include that gastric lavage may be useful. The compound is also noted as being easily dialyzable, which is a factor relevant to management, particularly for patients undergoing haemodialysis.

Therapeutic Uses of Tinidan

What Tinidan Treats: Main Uses and Benefits

The medication Tinidan (Tinidazole) is a targeted anti-infective agent generally used to help manage the presence of specific protozoal and anaerobic bacterial pathogens, providing supportive therapeutic benefit by addressing the underlying infectious cause of symptomatic distress. The medication is applied across domains involving heightened patient discomfort and symptoms that interfere with daily functioning. The drug is indicated for the treatment of Trichomoniasis, Giardiasis, Amebiasis (both intestinal and liver abscess), and Bacterial Vaginosis in adult women.


Targeting Disruptive Gastrointestinal and Systemic Parasites

Tinidan is commonly used across conditions characterized by acute, disruptive symptom manifestations resulting from infections like Giardiasis and Amebiasis. It is applied to address symptom patterns that cluster into pronounced gastrointestinal distress, including persistent diarrhea, abdominal cramping, and gas. The therapy provides support that helps ease the overall symptom burden, assisting with maintaining functional stability during the acute phase of illness. It is considered relevant in clinical settings that involve severe manifestations, such as the extra-intestinal discomfort associated with Amebic Liver Abscess. It is also applied in clinical settings for pediatric patients (children) with Giardiasis or Amebiasis.

“The primary goal of this therapy is to target the root cause of certain protozoal and anaerobic bacterial infections to help the patient return to functional stability.”

Managing Symptoms of Genitourinary and Anaerobic Infections

This medication is applied in contexts where additional symptomatic support is needed due to infections of the genitourinary tract, specifically Trichomoniasis and Bacterial Vaginosis. It is used when symptoms create noticeable physiological strain, helping to address distressing manifestations such as abnormal discharge, irritation, and burning. The medicine helps manage symptoms related to inflammatory or irritative states, assisting with maintaining functional stability when symptoms become more noticeable. Furthermore, it is applied in addressing symptomatic discomfort in the sexual partner of a patient diagnosed with Trichomoniasis, which is relevant in managing potential reinfection.


Quick Fact: Relief for Infection-Driven Distress Tinidan is used for managing conditions that present with significant symptomatic burden, including acute diarrhea, severe abdominal discomfort, and bothersome genitourinary discharge, by targeting the specific protozoa and anaerobic bacteria causing the symptoms.

Regulatory References

  1. NIH DailyMed: Tinidazole Tablets

Eligibility and Restrictions for Use

Who Can and Cannot Use Tinidan?

Tinidan (Tinidazole) is a prescription anti-infective with specific eligibility rules established by regulatory authorities.

Tinidan is strictly contraindicated for individuals with:

  • A history of hypersensitivity (allergy) to tinidazole or any other nitroimidazole derivatives (e.g., metronidazole).
  • The first trimester of pregnancy.
  • Cockayne syndrome.
  • Consumption of alcohol or alcohol-containing products during therapy and for three days (72 hours) after the final dose.
  • Patients with organic neurological disorders or a history of blood dyscrasias.

Age-Related and Conditional Eligibility:

Population/Condition Official Eligibility Status
Pediatric Patients Approved for those older than three years of age for Giardiasis and Amebiasis. Use is not established for children 3 years and younger.
Lactating Women Not recommended; breastfeeding must be interrupted during therapy and for 72 hours following the last dose.
Hepatic Impairment Requires caution due to limited data and the liver's role in drug clearance.
Neurological Disorders Use requires caution; the drug must be discontinued if abnormal neurological signs develop.
Second/Third Trimester Pregnancy Use is permissible only if the benefits are judged to outweigh the potential risks.

All patients with known neurological or blood disorders, or severe liver impairment, should have their eligibility assessed carefully.

What should I know about interactions with other medicines?

The official interaction profile for Tinidan (Tinidazole) is defined by specific restrictions and pharmacokinetic alterations documented in regulatory sources.

Contravened Substances and Timing Rules

Co-administration of alcohol (ethanol-containing products) is strictly contraindicated during therapy and for at least 72 hours following the final dose, due to the risk of a severe Disulfiram-like reaction. A mandatory timing-based interaction rule dictates that Tinidan must not be administered within two weeks of discontinuing Disulfiram due to the potential for psychotic reactions documented in labeling.

Pharmacokinetic and Pharmacodynamic Interactions

Tinidan exhibits a pharmacodynamic interaction with oral coumarin anticoagulants, such as Warfarin, by potentiating their effect, a factor which requires close monitoring of the patient's coagulation status.

The drug's plasma exposure is subject to metabolic modulation involving liver enzymes. Cimetidine may increase Tinidazole plasma concentrations by inhibiting its clearance. Conversely, enzyme inducers like Phenobarbital and Rifampin may decrease Tinidazole exposure through increased elimination. The drug may be administered with or without food, as food does not alter its oral bioavailability.

Population-Specific Note

For patients diagnosed with severe hepatic impairment, the drug's overall clearance is reduced, which may lead to drug accumulation and potentially heighten the interaction risk with co-administered medicines.

Mechanism of Action

The action of Tinidazole is defined by a highly specific process of selective chemical cytotoxicity, exploiting metabolic differences between host cells and pathogens, resulting in pathogen cell death.


Prodrug Activation and Selective Toxicity

Tinidazole functions as an inactive prodrug that must be reduced by unique low-redox potential enzymes (like ferredoxin) found in susceptible anaerobic bacteria and protozoa. This selective activation generates highly reactive nitro radicals exclusively within the microbe, which is the mechanism that is the basis for the drug's selective toxicity against the pathogen over host cells.


Cytotoxic Cascade and DNA Damage

Once generated, the highly reactive nitro radicals aggressively covalently bind to the microbe's essential DNA and structural proteins. This irreversible damage halts crucial DNA synthesis and repair functions, initiating a cytotoxic cascade that leads directly to the death of the susceptible pathogen.


Biological Constraints and Mechanism Limitations

This cellular effect is entirely dependent on the low-oxygen internal environment required for prodrug activation; therefore, the mechanism is ineffective against most aerobic organisms. Furthermore, any changes in the pathogen's redox pathways can lead to reduced prodrug activation, which acts as a direct constraint on the drug's ability to produce the cytotoxic effect.

Dosage and Administration Information

Tinidan (Tinidazole) is an anti-infective agent administered exclusively via the oral route. It is provided as 250 mg and 500 mg film-coated tablets; for patients unable to swallow solid forms, a liquid suspension for oral use can also be prepared extemporaneously from the tablet form. The standard administration pattern involves short courses, ranging from a single day up to a maximum of five days, depending on the specific condition being addressed.

Official Dosing and Frequency

The dosing regimen for Tinidan is specifically tailored to the approved condition. Several conditions, including Trichomoniasis and Giardiasis, are managed with a single oral dose of 2 g. For other conditions, such as Intestinal Amebiasis and Bacterial Vaginosis (depending on the regimen), the drug is administered once daily (1 g or 2 g) over a course of two to five days.

Key Procedural Conditions

Official guidance specifies that Tinidan must be taken with food, regardless of whether the tablet or liquid form is used. For pediatric patients, the drug is approved for use in children older than three years of age, with the dose calculated based on 50 mg/kg per day, not to exceed the adult daily maximum of 2 g. A critical procedural requirement is the strict avoidance of alcohol during the entire course of therapy and for a period of at least 72 hours (three full days) following the final dose. Additionally, when treating Trichomoniasis, official instructions specify that the patient's sexual partner must receive concurrent treatment.

Recent Clinical Evidence

Research evidence / Overview of studies for Tinidan


Evidence for Use in Protozoal Infections: Giardiasis and Intestinal Amebiasis

The evidence base for Giardiasis and Intestinal Amebiasis includes clinical trials, such as randomized controlled trials (RCTs) and open-label studies. This research evaluated the research endpoints for conditions such as Giardiasis and symptomatic Intestinal Amebiasis, focusing on outcomes related to parasitological clearance and symptom change. Research monitored outcomes related to physical discomfort, such as abdominal cramping and diarrhea, that were measured during the study period. What remains uncertain is that follow-up durations were limited in many trials, meaning there is limited information for long-term outcomes to fully characterize functional stability.

Evidence for Use in Genitourinary Infections: Trichomoniasis and Bacterial Vaginosis

The evidence base for Trichomoniasis and Bacterial Vaginosis (BV) includes multiple randomized controlled trials (RCTs) and systematic reviews. This research explored research endpoints for conditions including Trichomoniasis and Bacterial Vaginosis. Studies monitored outcomes related to both parasitological clearance and clinical cure. For BV, research examined short-term changes in both clinical indicators and microbiological outcomes (measurements related to vaginal flora patterns). The evidence quality varies across studies, and meta-analyses note that the findings were mixed due to high heterogeneity in trial designs for Bacterial Vaginosis.


Long-Term Studies and Research Gaps

Research exploring short-term symptom changes exists; however, long-term effects are not fully established across most indications. The majority of studies observed responses over defined time intervals of only a few weeks to assess the initial effect. Data describing sustained outcomes for conditions characterized by fluctuating or episodic manifestations are still emerging. Furthermore, the data for certain groups remain insufficient, including populations with specific compromised immune statuses or those with documented resistance to similar anti-infective agents.

Key Studies & References

  1. Tinidazole: DailyMed Label Information
  2. Tinidazole (Systemic): MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Tinidan (FAQ)


Q: Is Tinidan used to treat anything other than its main approved condition?

Official regulatory documents indicate that Tinidan has approved uses for several specific types of infections. These conditions include Trichomoniasis, Giardiasis, and certain forms of Amebiasis (intestinal and liver abscess), as well as Bacterial Vaginosis. The official label defines these conditions as the intended targets for the drug.


Q: Is Tinidan known to interact with common pain relievers or over-the-counter medicines?

While the official drug label primarily details interactions with prescription medicines, reviews based on regulatory data suggest that there is no major interaction reported with common over-the-counter pain relievers such as ibuprofen or acetaminophen. Providing all information about over-the-counter products taken to a healthcare professional allows for safe use assessment.


Q: Does Tinidan cause drowsiness or affect the ability to drive?

Adverse reactions listed in official regulatory sources include effects on the nervous system such as dizziness and drowsiness (sleepiness). These effects may require caution when operating machinery or driving.


Q: Are there any known issues with alcohol consumption while taking Tinidan?

Co-administration with alcohol is strictly contraindicated. The official label notes that combining the drug with alcohol may cause a severe reaction referred to as a Disulfiram-like reaction. This reaction can include symptoms such as severe nausea, vomiting, fast heartbeats, sweating, and flushing (warmth/redness) of the skin.


Q: Can I take vitamins or supplements along with Tinidan?

Regulatory guidance emphasizes the importance of providing full information to a prescribing healthcare professional about all medicines, including vitamins, mineral supplements, and herbal supplements, due to the risk of interactions. This helps ensure proper medical oversight.


Q: Can Tinidan be used indefinitely, or is it only for short-term treatment?

Official regulatory documents advise healthcare providers to avoid chronic or unnecessary use of Tinidan. Therefore, the drug is typically limited to its approved, short-term treatment courses, which usually last no more than a few days.


Q: Is Tinidan safe for older adults to use?

Studies performed to date have not established specific problems that would limit the drug's use in elderly (geriatric) populations. However, older patients may be more likely to have age-related decline in liver or kidney function. Any existing age-related decline in organ function may necessitate the consideration of a dose adjustment by a healthcare professional.


Q: Are there any long-term health concerns associated with using Tinidan?

Serious effects, such as peripheral neuropathy (nerve damage leading to numbness or tingling), are noted as a safety consideration specifically linked to prolonged administration of the drug. For this reason, regulatory documents advise that the use of Tinidan should be limited and chronic treatment avoided.


Q: Is it normal to feel a change in appetite while taking Tinidan?

Yes, official regulatory sources classify a decreased appetite or loss of appetite as a common side effect. If this symptom becomes severe or causes concern, a review by a healthcare provider may be appropriate.


Q: Is Tinidan known to affect mood or mental focus?

Official adverse reaction summaries include reports of rare effects on the mental state. These can include depression, confusion, and general mood or mental changes. Awareness of these potential symptoms is generally recommended.


Q: Are there any specific lab tests that are needed when starting Tinidan?

Regulatory documents advise caution in individuals with a history of certain blood disorders (blood dyscrasias). Because the drug may transiently decrease some white blood cells (leukopenia and neutropenia), a healthcare professional may deem monitoring blood counts appropriate.


Q: Is it possible to be allergic to an inactive ingredient in Tinidan?

The drug is contraindicated (strictly forbidden) for patients with known hypersensitivity to the active ingredient or related compounds. The official label also contains a complete List of Excipients (inactive ingredients). The information allows patients to check the list against any known allergies and discuss it with their healthcare professional.


Q: Is Tinidan a controlled substance?

Regulatory information and government scheduling systems confirm that Tinidan is not a controlled substance and is not subject to the strict regulations associated with controlled drugs.


Q: How does the body break down and eliminate Tinidan?

According to official clinical pharmacology data, the drug is primarily metabolized (broken down) in the liver, mainly by a specific enzyme called CYP3A4. It is then eliminated from the body with an overall half-life of 12–14 hours.


Q: Does Tinidan have different restrictions in other countries?

Yes, the regulatory status of the drug and its specific prescribing restrictions can vary depending on the country or region. For instance, the exact legal classification (e.g., Prescription-only or Pharmacy Medicine) and required labeling may differ internationally.


Q: Can Tinidan cause weight changes?

Official adverse reaction summaries note that loss of appetite is a common side effect. Less commonly, weight loss has also been reported as an adverse reaction in clinical experience summaries.


Q: Is Tinidan generally considered safe for use during breastfeeding?

Official instructions recommend that breastfeeding must be interrupted during the entire course of therapy and for at least 72 hours (three full days) after the final dose. Any milk expressed during this period should be discarded.


Q: Are there different brand names for the same active ingredient as Tinidan?

Yes, the active ingredient in Tinidan is called Tinidazole. This compound is sold under different brand names, such as Tindamax, in the United States, and it may be available under other trade names internationally, as well as in generic forms.

How should Tinidan be stored and disposed of?

How to Store and Dispose of Tinidan

Tinidan tablets must be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F). The medication must be kept from freezing and stored away from excessive heat and moisture. It is a mandatory requirement to protect from light and keep the tablets in a tightly closed container.

Child Safety and Stability

As a safety precaution, Tinidan must be stored out of the sight and reach of children.

If the medication is prepared as an oral liquid suspension, it is stable for only 7 days when kept at room temperature, after which any remaining portion must be discarded.

Disposal Instructions

Expired or unused Tinidan must be disposed of in accordance with local requirements. Patients must ask a healthcare professional or pharmacist how to properly discard the medicine and should not flush it down a toilet or pour it down a drain unless specifically advised to do so.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tinidan found in:

A-Z Index: